This product is intended for research purposes only
However, we think that the use of this protocol in non-anaphylactic immediate reactions in the presence of appropriate indications will provide the expected benefit
Temperature: 18C -25C
For adults with T2D at high risk of major CV events Ozempic (semaglutide) pill: proven CV risk reduction 6 (semaglutide) pill: proven CV risk reduction 6 Start Ozempic pill today in adults with T2D who are at high risk for major CV events Ozempic pill can significantly lower the risk of MACE 6,7 pill can significantly lower the risk of MACE 6,7 Primary composite endpoint: Reduction in risk of MACE with semaglutide tablets 14 mg vs placebo when both were added to SOC in adults with T2D and established CVD and/or CKD 6 Time to first confirmed MACE (CV death, nonfatal MI, or nonfatal stroke) 6,7,b NNT 50 Number needed to treat to prevent d 1 MACE (3 years) 7,d Ozempic tablets 1.5 mg, 4 mg, and 9 mg are an updated formulation with increased bioavailability

13 A placebo-controlled trial with 125 healthy participants reporting moderate-to-high perceived stress levels found 300 mg of a sustained-release ashwagandha formulation for 90 days improved memory and focus, reduced cortisol levels, and improved sleep quality and psychological well-being
Retatrutide refers to a peptide known as LY3437943, which acts on three receptors: the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R)